الخميس 10 محرم 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia | Vertex / CTI | Ongoing | VX 880 | 3 | VX20-880-101 | King Abdulaziz Hospital NG (Riyadh) |
| Evaluation of safety and efficacy of non-anesthesia provider-administered different anesthetic regimens during colonoscopy: a single center, prospective double blind, randomized study | PI initiated | Ongoing | Propofol | 4 | 6074515 | King Saud Hospital (Unaizah) |
| A global phase 3, randomised, double-blind and placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease | Novo Nordisk | Ongoing | Etavopivat | 3 | NN7535-7807 | King Abdulaziz Hospital NG (Al Ahsa) ,King Faisal Specialist Hospital and Research Center ,(Riyadh) Imam Abdulrahman Al Faisal Hospital NG (Dammam) |
| Registry-based study of patients treated with exagamglogene autotemcel (exa-cel) in the Kingdom of Saudi Arabia | Vertex | Ongoing | Exagamglogene autotemcel (Casgevy) | 4 | 290-103 | - |
| A Phase II/III, Extension Study of Orally Administered PHA-022121 for Acute Treatment of Angioedema Attacks in Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency (Type I or Type II (RAPIDe-2) | Pharvaris Netherlands B.V. | Ongoing | Deucrictibant | 2/3 | PHA022121-C303 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Patient and prescriber survey: effectiveness measures to investigate awareness, knowledge, and adherence to the additional risk minimisation measures (aRMM) of the patient reminder card for oral ambrisentan (PrVolibris®) | GSK | Ongoing | Ambrisentan | 4 | 221772 | King Abdullah International Medical Research Center– Jeddah |
| A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lutikizumab in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa | AbbVie Biopharmaceuticals GmbH ScientificOffice | Ongoing | Lutikizumab | 3 | M20-465 | King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz Medical City NG (Jeddah) |
| Real-world evidence Non-Interventional proSpective study of kisqaLi (Ribociclib) Effectiveness and safety in patients with HR+/HER2- early Breast Cancer in Saudi Arabia | Novartis Saudi Ltd | Ongoing | kisqaLi (ribociclib) | 2 | CLEE011ASA | King Abdulaziz Medical City NG (Riyadh), King Khalid University Hospital (Riyadh) |
| A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Renal Outcomes and Cardiovascular Mortality in Participants with Chronic Kidney Disease and High Blood Pressure | Astrazeneca | Ongoing | D6972C00002 | 3 | D6972C00002 | King Faisal Specialist Hospital and Research Center (Riyadh) ,King Fahad Specialist Hospital (Dammam) ,King Fahad Medical City (Riyadh) ,King Abdulaziz Hospital NG (Al Ahsa), King Abdulaziz Medical City NG (Riyadh) |
| Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c 2.4 mg Once-weekly | Novo Nordisk | Ongoing | Semaglutide | 3 | NN9536-7752 | King Khalid University Hospital (Riyadh) ,King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Hospital NG (Al Ahsa), King Abdulaziz Medical City NG (Jeddah) ,King Faisal Specialist Hospital and Research Center (Riyadh) |
تاريخ آخر تحديث: 08/05/2025 بتمام الساعة 03:17 مساء بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.